The use of adjuvant endocrine breast cancer therapy in the oldest old

Breast

Volumn 22, Issue 5, 2013, Pages 863-868

  Güth, Uwe ^a,b,c   Myrick, Mary Elizabeth ^d   Kandler, Christian ^e   Vetter, Marcus ^a,f  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

^c Breast Center SenoSuisse   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e Division for Geriatrics   (Switzerland)

^f NONE   (Switzerland)

Author keywords

Breast cancer; Compliance; Endocrine therapy; Oldest old; Persistence

Indexed keywords

ANASTROZOLE; EXEMESTANE; FULVESTRANT; LETROZOLE; TAMOXIFEN; TRASTUZUMAB;

ADULT; AGE; AGED; ALCOHOLISM; ARTHRALGIA; ARTICLE; BONE PAIN; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CLINICAL FEATURE; DRUG WITHDRAWAL; ELDERLY CARE; EMBOLISM; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; GERIATRIC PATIENT; HAIR LOSS; HISTOPATHOLOGY; HOT FLUSH; HUMAN; HYPERTENSION; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALAISE; MEDICATION COMPLIANCE; MENTAL DISEASE; MUSCULOSKELETAL DISEASE; ONCOLOGIST; PARTIAL MASTECTOMY; PATIENT COMPLIANCE; PRIORITY JOURNAL; SIDE EFFECT; SKIN MANIFESTATION; THROMBOSIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; VERY ELDERLY; VISUAL DISORDER; WEIGHT GAIN;

BREAST CANCER; COMPLIANCE; ENDOCRINE THERAPY; OLDEST OLD; PERSISTENCE;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; GENERAL PRACTICE; GERIATRICS; HUMANS; MEDICATION ADHERENCE; PHYSICIAN'S PRACTICE PATTERNS; TAMOXIFEN; TREATMENT REFUSAL; WITHHOLDING TREATMENT;

EID: 84884162682     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2013.03.001     Document Type: Article

References (36)

1. Albrand G., Terret C. Early breast cancer in the elderly: assessment and management considerations. Drugs Aging 2008, 25(1):35-45.
2. Biganzoli L., Wildiers H., Oakman C., Marotti L., Loibl S., Kunkler I., et al. Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol 2012, 13(4):e148-e160.
3. Crivellari D., Aapro M., Leonard R., von Minckwitz G., Brain E., Goldhirsch A., et al. Breast cancer in the elderly. JClin Oncol 2007, 25(14):1882-1890.
4. Ring A., Reed M., Leonard R., Kunkler I., Muss H., Wildiers H., et al. The treatment of early breast cancer in women over the age of 70. Br J Cancer 2011, 105(2):189-193.
5. Spazzapan S., Crivellari D., Bedard P., Lombardi D., Miolo G., Scalone S., Veronesi A. Therapeutic management of breast cancer in the elderly. Expert Opin Pharmacother 2011, 12(6):945-960.
6. Taylor W.C., Muss H.B. Recent advances: adjuvant therapy for older women with breast cancer. Cancer J 2010, 16(4):289-293.
7. Peto R., Davies C., Godwin J., Gray R., Pan H.C., et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 2012, 379:432-444. Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
8. Demissie S., Silliman R.A., Lash T.L. Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. JClin Oncol 2001, 19(2):322-328.
9. Fink A.K., Gurwitz J., Rakowski W., Guadagnoli E., Silliman R.A. Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer. JClin Oncol 2004, 22(16):3309-3315.
10. Lash T.L., Fox M.P., Westrup J.L., Fink A.K., Silliman R.A. Adherence to tamoxifen over the five-year course. Breast Cancer Res Treat 2006, 99(2):215-220.
11. Neugut A.I., Subar M., Wilde E.T., Stratton S., Brouse C.H., Hillyer G.C., et al. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. JClin Oncol 2011, 29(18):2534-2542.
12. Owusu C., Buist D.S., Field T.S., Lash T.L., Thwin S.S., Geiger A.M., et al. Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. JClin Oncol 2008, 26(4):549-555.
13. Silliman R.A., Guadagnoli E., Rakowski W., Landrum M.B., Lash T.L., Wolf R., et al. Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. JClin Oncol 2002, 20(11):2680-2688.
14. Weggelaar I., Aben K.K., Warle M.C., Strobbe L.J., van Spronsen D.J. Declined guideline adherence in older breast cancer patients: a population-based study in the Netherlands. Breast J 2011, 17(3):239-245.
15. Ziller V., Kalder M., Albert U.S., Holzhauer W., Ziller M., Wagner U., et al. Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. Ann Oncol 2009, 20(3):431-436.
16. Blackman S.B., Lash T.L., Fink A.K., Ganz P.A., Silliman R.A. Advanced age and adjuvant tamoxifen prescription in early-stage breast carcinoma patients. Cancer 2002, 95(12):2465-2472.
17. Schonberg M.A., Marcantonio E.R., Li D., Silliman R.A., Ngo L., McCarthy E.P. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. JClin Oncol 2010, 28(12):2038-2045.
18. Van Leeuwen B.L., Rosenkranz K.M., Feng L.L., Bedrosian I., Hartmann K., Hunt K.K., et al. The effect of under-treatment of breast cancer in women 80 years of age and older. Crit Rev Oncol Hematol 2011, 79(3):315-320.
19. Vetter M., Huang D.J., Bosshard G., Guth U. Breast cancer in women 80 years of age and older: a comprehensive analysis of an underreported entity. Acta Oncologica 2013, 52(1):57-65.
20. AJCC cancer staging manual 2009, Springer, New York. 7th ed. S. Edge, D. Byrd, C. Compton, A.G. Fritz, F.L. Greene, A. Trotti (Eds.).
21. UICC: TNM classification of malignant tumors 2009, Wiley-Blackwell, Oxford. 7th ed. L. Sobin (Ed.).
22. Andrade S.E., Kahler K.H., Frech F., Chan K.A. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006, 15(8):565-574. [discussion 75-7].
23. Barron T.I., Connolly R., Bennett K., Feely J., Kennedy M.J. Early discontinuation of tamoxifen: a lesson for oncologists. Cancer 2007, 109(5):832-839.
24. Osterberg L., Blaschke T. Adherence to medication. NEngl J Med 2005, 353(5):487-497.
25. Güth U., Huang D.J., Schotzau A., Zanetti-Dällenbach R., Holzgreve W., Bitzer J., et al. Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer. Br J Cancer 2008, 99(3):428-433.
26. Partridge A.H., LaFountain A., Mayer E., Taylor B.S., Winer E., Asnis-Alibozek A. Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. JClin Oncol 2008, 26(4):556-562.
27. Partridge A.H., Wang P.S., Winer E.P., Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. JClin Oncol 2003, 21(4):602-606.
28. Guth U., Myrick M.E., Kilic N., Eppenberger-Castori S., Schmid S.M. Compliance and persistence of endocrine adjuvant breast cancer therapy. Breast Cancer Res Treat 2012, 131(2):491-499.
29. Bouchardy C., Rapiti E., Blagojevic S., Vlastos A.T., Vlastos G. Older female cancer patients: importance, causes, and consequences of undertreatment. JClin Oncol 2007, 25(14):1858-1869.
30. Litvak D.A., Arora R. Treatment of elderly breast cancer patients in a community hospital setting. Arch Surg 2006, 141(10):985-990. [discussion 90].
31. Berg A.I., Hassing L.B., Nilsson S.E., Johansson B. "As long as I'm in good health". The relationship between medical diagnoses and life satisfaction in the oldest-old. Aging Clin Exp Res 2009, 21(4, 5):307-313.
32. Yellen S.B., Cella D.F., Leslie W.T. Age and clinical decision making in oncology patients. JNatl Cancer Inst 1994, 86(23):1766-1770.
33. Steinhauser K.E., Christakis N.A., Clipp E.C., McNeilly M., McIntyre L., Tulsky J.A. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 2000, 284(19):2476-2482.
34. Downey L., Livingston R., Stopeck A. Diagnosing and treating breast cancer in elderly women: a call for improved understanding. JAm Geriatr Soc 2007, 55(10):1636-1644.
35. Hong S., Didwania A., Olopade O., Ganschow P. The expanding use of third-generation aromatase inhibitors: what the general internist needs to know. JGen Intern Med 2009, 24(Suppl. 2):S383-S388.
36. Kanapuru B., Ershler W.B., Hesdorffer C., Jemal A., Yates J.W. Long-term survival of older breast cancer patients: population-based estimates over three decades. Breast Cancer Res Treat 2012, 134(2):853-857.